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The  complement  pathway  is  most  famous  for  its role  in  immunity,  orchestrating  an  exquisitely  reﬁned
system  for  immune  surveillance.  At  its core  lies  a cascade  of  proteolytic  events  that  ultimately  serve
to  recognise  microbes,  infected  cells  or  debris  and  target  them  for  elimination.  Mounting  evidence  has
shown  that  a number  of the  proteolytic  intermediaries  in  this  cascade  have,  in  themselves,  other  func-
tions  in the  body,  signalling  through  receptors  to  drive  events  that appear  to be  unrelated  to  immunehemotaxis surveillance.  It seems,  then,  that  the  complement  system  not  only  functions  as  an  immunological  effector,
but  also has cell–cell  signalling  properties  that are utilised  by a number  of  non-immunological  processes.
In  this  review  we  examine  a number  of  these  processes  in  the  context  of  animal  development,  all  of
which  share  a  requirement  for precise  control  of  cell  behaviour  in  time  and  space.  As  we will  see,  the
scope  of the complement  system’s  function  is  indeed  much  greater  than  we might have imagined  only  a
few  years  ago.. Introduction
The complement system is one of the most ancient immunologi-
al systems, with origins in some of the earliest metazoans [1–3]. At
ts core lies a cascade of activation steps, many of which drive pro-
eolytic cleavages of pro-proteins into activated effectors (Fig. 1).
he system is vast and a detailed description of the many compo-
ents involved can be found in [4]. For the purposes of this review,
e will present only the components of the system that are most
elevant to the processes described below.
The complement system is activated via three independent
athways that converge on the cleavage of C3 into the fragments
3a and C3b. In the classical pathway, complement activation is
riggered by C1, which is composed of C1q, C1r and C1s. Acti-
ation of C1q is often initiated by IgM or IgG clusters, and this
auses the consecutive activation of C1r and C1s. C1s, in turn,
leaves C4 to generate C4a and C4b and can cleave C4b-bound C2
o produce C4b2b, which drives the activation of C3 (Fig. 1). The
ectin pathway is mechanistically similar to the classical pathway:
annose-binding lectins (MBLs) recognise carbohydrates on the
urfaces of pathogens, and their associated mannan-binding lectin
erine peptidases (MASPs), like C1s, can cleave C4 and C2 to gener-
te the C3 convertase C4b2b as above (Fig. 1). The alternate pathway
s involved in surveillance of self versus non-self on all cells, and
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functionally serves to keep the immune system at an idle speed.
It also drives the activation of C3 into C3a and C3b, but a detailed
description of the molecules underlying alternative pathway acti-
vation is beyond the scope of this review.
Downstream of C3 cleavage C3b production triggers cleavage
of C5 into C5a and C5b. C5b in turn recruits C6, C7, C8 and sev-
eral C9 molecules to generate the membrane attack complex (MAC,
or C5b-9n), which assembles in the plasma membrane of target
cells, generating cytolyic pores (Fig. 1). Although osmotic lysis is
one result of complement system activity, there are many other
processes driven by complement system components. The anaphy-
latoxins C3a and C5a, which are critical for immune responses and
inﬂammation, signal via their G-protein-coupled receptors C3aR
and C5aR, respectively. Both C3a and C5a are strong chemoattrac-
tants, directing neutrophil, macrophage and monocyte migration.
As we shall see, the interactions between these ligands and their
receptors also drive several important developmental processes.
Additionally, C3b can be tagged by factor I (fI); iC3b can bind
another receptor, CR3, to trigger additional downstream effects.
Even the MAC  itself can have signalling roles that are different from
its function as a lytic pore [5,6], as we will discuss later.
Thus, the complement system includes a vast array of ligands,
receptors and regulators that can drive a large number of signalling
events. While all of these are involved in immune surveillance,
Open access under CC BY license.many are also found in other contexts. For example, some members
of the complement pathway are important for neuronal elimination
during brain development (reviewed in [7]). This observation is not
entirely surprising: pruning of synaptic connections is an important
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Fig. 1. The complement pathway in development. Simpliﬁed representation of the core components of the complement system. Proteins known to be involved in develop-
mental or regenerative processes and discussed herein are highlighted in yellow; those expressed during development or regeneration are outlined in purple. Complement
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aystem activation can occur via three separate pathways, the classical, the lectin and
3b.  C3a can signal via C3aR, while C3b production leads to the cleavage of C5. C3b
ignal  transduction via C5aR, and C5b initiates the assembly of the MAC by recruit
ith  C5b-9 to form a soluble form of the MAC, called SC5b-9. fB, factor B; fD, factor
art of the neuronal development, and elimination of neurons in
ater stages of development has been well documented [8,9]. Thus,
t seems that development and immunology may  have evolved to
hare the same mechanisms for ridding the body of unwanted cells.
Yet the complement system also has other developmental
esponsibilities that extend well beyond the realm of cell clearance.
enopus embryos express a number of complement components
uring the early stages of development [10,11]. These early pat-
erns of expression are not limited to amphibians: recent evidence
uggests that they may  be shared by other vertebrates, such as
sh [12], mice [13,14] and humans [14]. These ﬁndings have led
o surprising ﬁndings about how the complement pathway helps
o drive morphogenetic movements during development through
omewhat unexpected mechanisms [12,15–17].
In this review, we will discuss these observations in more detail
nd present our current understanding of many of the ways inlternative pathways. These converge at the level of C3 cleavage, generating C3a and
lso be tagged by factorI (fI) to yield iC3b, which can signal via CR3. C5a can trigger
, C7, C8 and a number of C9 molecules. S-protein/vitronectin (S) can also complex
which the complement pathway contributes to animal develop-
ment. In many cases, we are only beginning to appreciate the scope
this involvement. Yet as we learn more about this complex sys-
tem, we begin to see a picture of a pathway whose diverse roles in
non-immunological processes is indeed remarkable.
2. The complement pathway in development
2.1. Synapse elimination
For years it was  believed that the immune system played no
role in the central nervous system, neither during development
nor in adult life. This concept of “immune privilege” was  largely
based on the low level of expression of immune system proteins
on the surfaces of CNS cells (for example, MHC class I proteins) or
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he sluggish response of CNS cells to immune challenges in vivo
nd in vitro (reviewed in [18]). Recently, however, this notion has
een challenged. With increasingly sensitive methods of detection
t has become clear that molecules such as MHC  class I and its
ffectors, cytokines and their receptors and complement pathway
omponents are important during CNS development [14,19–23].
f these, MHCI and cytokines are the most well-documented, with
oles most often described in the context of synaptic reﬁnement
nd plasticity [20,23–29]. Yet our understanding of how MHCI and
ytokines signal during axonal pathﬁnding and synaptic reﬁne-
ent is far from complete, largely due to the massive degree of
omplexity associated with MHCI and cytokine signalling [23].
More recently, the complement system has also been shown
o play important roles during neural development. At birth, the
ouse brain contains excessive numbers of neuronal connections
etween the retina and the dorsal lateral geniculate nucleus (dLGN)
n the brain. This number is reduced during the ﬁrst few weeks of
ife in a process termed synaptic elimination [30,31], and it seems
hat both C1q and C3 are crucial for this to occur properly (Fig. 2A).
n a seminal 2007 study, Stevens and colleagues showed that com-
lement components C1q and C3 are expressed in neonatal retinal
anglion cells (RGCs), the neurons that form these connections.
his expression appears to be driven by neighbouring astrocytes
y a hitherto unknown mechanism and results in the accumula-
ion of both proteins at synapses. This accumulation is lost in older
ice, indicating that its role is primarily a developmental one. In
ice lacking either protein, synaptic elimination failed and exces-
ive RGC innervation in the dLGNs was observed [13]. Thus, the
omplement pathway plays a role in normal brain development by
ediating the elimination of unwanted neuronal connections.
If the complement system helps to eliminate unwanted neu-
onal connections during development, one might suppose that
berrant complement activity could be involved with neuronal
egeneration during diseases or in response to injury. Indeed,
t has been found that C1q, C1s and C3 are up-regulated dur-
ng glaucoma, a form of eye disease characterised by RGC death
13], and that loss of C1q could ameliorate the severity of the dis-
ase [32]. Interestingly, C1q knock-out mice also showed signs of
pilepsy resulting from enhanced excitatory synaptic connectivity
33]. Thus, the complement system appears to play a major role
n the elimination of neurons, both during normal development
nd also in the progression of some forms of neurodegenerative
isease [34]. Furthermore, complement factors also participate in
ther pathological neurodegenerative situations that involve elimi-
ation of neuronal connections, such as hypoxic ischaemia or spinal
otoneuron injury [35].
Thus, the complement pathway is involved with synapse elimi-
ation both during normal development and in situations of disease
r injury. In the case of RGCs, this appears to be mediated by
icroglia via CR3/C3 signalling [36]. Similar ﬁndings have been
hown in studies on glaucoma [37] and brain ischaemia [35,38].
hether the exact mechanism driving elimination in these disease
tates is the same as those observed during normal development
emains to be determined.
.2. Cell migration and morphogenesis
The ﬁndings discussed above give us important clues about
on-immunological functions of complement pathway compo-
ents. In both synapse elimination and immunological surveillance,
he interactions between cells must be precisely controlled in
ime and space. One might predict, therefore, that other processes
hat require the careful orchestration of cell behaviour might also
ely on complement-mediated signalling. An example of such a
rocess is collective cell migration, the coordinated migration of
ell clusters that has been observed during embryo development,munology 25 (2013) 39– 46 41
cancer metastasis and wound healing [39–41]. We ﬁnd examples of
collective cell migration in a number of morphogenetic processes,
such as border cell migration in Drosophila,  lateral line development
in zebraﬁsh and neural crest migration in all vertebrates. Collec-
tive cell migration is not merely a collection of individual cells
independently migrating towards the same target. Rather, it is a
coordinated movement that requires cell–cell contacts to establish
polarity across the cluster that, in turn, drives all of the cells within
the cluster to persistently move in the desired direction [42,43]. In
the neural crest, for example, all cells within a cluster will move
steadily towards a chemoattractant such as the chemokine Sdf1,
but isolated cells are almost completely unresponsive to Sdf1 [43].
Thus, efﬁcient communication between neural crest cells is essen-
tial if the cells are to ﬁnd their correct paths, and investigations
into the mechanisms underlying this communication have revealed
surprising, non-immunological roles for the complement pathway.
To understand how complement signalling affects neural crest
behaviour, one must ﬁrst understand a bit about the developmen-
tal roles of this extraordinary group of cells. During development,
neural crest cells delaminate from the dorsal boundary of the neu-
ral tube and migrate ventrally in streams. Their route is dictated
by positive and negative guidance cues that enable the cells to pio-
neer the formation of many structures of the adult body such as
the muscle, bones and nerves in the head, neurons and glia of the
peripheral nervous system and pigments in the skin, among oth-
ers [44,45]. Because neural crest cells are mesenchymal, they form
relatively transient cell–cell junctions with one another. Curiously,
they also undergo a form of repulsion called contact inhibition of
locomotion (CIL). In CIL, motile cells that collide cease their migra-
tion, repolarise and adopt a new trajectory that aims them away
from the point of contact (Fig. 2B) [42,46–48]. In other words,
CIL drives cells apart. How, then, can a population of cells that
normally repel one another coordinate their efforts to migrate as
a group?
Part of the answer comes from a counteracting force termed
co-attraction (CoA) or mutual attraction between neighbour cells,
and it seems that the complement pathway plays an important
role in its execution. Recent work has shown that complement C3a
is crucial to CoA: C3a is released by migrating neural crest cells,
which also express the cognate C3a receptor (C3aR) on their sur-
faces (Fig. 2B) [12]. Both molecules are required for proper neural
crest cell migration in vivo: removal of either molecule resulted in
neural crest dispersion and loss of collective migration. Strikingly,
expressing both C3a and C3aR in myeloid cells, which normally
migrate as individuals, imposes collective migratory behaviour on
them. Thus, C3a–C3aR-mediated signalling between neural crest
cells within a cluster helps to attract cells towards one another,
thereby counter-balancing the forces of CIL that serve to drive them
apart (Fig. 2B). The result is a cluster of migrating cells whose col-
lective migration is far more productive than that of any one cell as
an individual [39].
How does C3a–C3aR signalling exert its effect? Normally
signalling via the Rho GTPase Rac1 at the leading edge of a migra-
tory cluster triggers the persistence of lamellipodial protrusions
in the direction of migration [43,49,50]. This polarity at the front
of a neural crest cluster in turn imposes directionality to the rest
of the group. When C3a–C3aR signalling is blocked Rac1 activa-
tion at the leading edge of a migratory neural crest clusters is
lost and the cluster fails to migrate effectively [12]. These ﬁnd-
ings echo those of Shinjyo and colleagues, who  showed that C3a
signalling is important in controlling the migration and differen-
tiation of neural progenitor cells (NPCs) [51]. The authors found
that C3a modulated NPC response to Sdf1 by altering levels of
Erk1/2 signalling. The involvement of downstream signal transduc-
tion cascades in complement-mediated events will be discussed in
more detail below (Section 3).
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Fig. 2. Developmental processes requiring signalling by the complement pathway. (A) Model of synaptic elimination in the mouse brain. Shortly after birth, many RGCs
(R)  make synaptic connections to the LGN. During the next few weeks, this number is reduced via synaptic elimination. RGCs produce C1q and C3, which is recognised by
CR3-expressing microglia (m), enabling them to target a subset of the RGCs for elimination (red X), thus ensuring that the correct number of RGCs remains; (B) neural crest
migration in a generic embryo. During neural crest migration (left side) repulsive forces of contact inhibition of locomotion (CIL, red) are offset by co-attractive forces (CoA,
green),  mediated by C3a–C3aR signalling. (Right side) Possible manner in which CL-K1–MASP interaction provides guidance cues to migrating neural crest cells; and (C)
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urprisingly, both genes are transcribed in both structures (not shown).
The development of neural crest cells and the structures that
hey generate is one of the more striking examples of develop-
ental morphogenesis. Because complement-mediated signalling
s critical for proper neural crest migration, one might predict
hat defects in complement pathway signalling might cause devel-
pmental abnormalities associated with aberrant neural crest
athﬁnding. Recent studies into the genetic causes of a group of
uman diseases have shown this to be the case.
3MC  syndrome is a collection of four previously described
uman genetic disorders sharing similar phenotypes including
efects in the formation of facial, ocular and otic structures [52,53],ound epithelium (we, orange) whereas C3 is localised to the blastema (bl, blue).
suggesting defects in the migration of neural crest cells. Linkage
analysis revealed that 3MC  syndrome is caused by mutations in
two genes, MASP1 and COLEC11 [15,17]. MASP1 encodes several
MASP isoforms that are involved in the MBL  branch of the com-
plement pathway (Fig. 1) [54]. In innate immunity, MBL  binds
carbohydrates on the surfaces of bacteria. MASP proteins are asso-
ciated with MBLs and trigger the activation of the complement
cascade (Fig. 1) [4]. COLEC11 (collectin 11)  encodes the protein CL-
K1, a C-type lectin that, like MBL  proteins, contains a carbohydrate
recognition domain [55,56] and is therefore likely to be recognised
by MASP proteins. Loss of either COLEC11 or MASP1 in zebraﬁsh
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esulted in neural crest migratory defects and resultant malforma-
ions of the cranial cartilage [15]. Additionally, CL-K1 was able to
ct as a chemoattractant to neural crest cells in vivo and in vitro
nd was able to attract HeLa cells in culture [15].
Thus, components of the MBL  branch of the complement path-
ay aid in the guidance of neural crest cells during development
Fig. 2B). Yet exactly how this occurs on a molecular level is poorly
nderstood. Because CL-K1 and MASP proteins are secreted and
ormally associated with opsonisation of pathogens, we can only
peculate as to their mode-of-action in the migrating neural crest.
ne attractive possibility is that CL-K1-associated MASP acts as a C3
onvertase, generating the release of C3a, which, in turn, facilitates
o-attraction via C3aR as described above. However, many of the
ASP1 mutations in 3MC  pedigrees were located in exon 12 [15,17],
hich encodes an alternately spliced serine protease domain; the
rotein product of this isoform, termed MASP3, appears to lack
he ability to cleave C2, C4 or C3, suggesting that the mechanism
nderlying its action is independent of MBL-driven complement
ctivation [57].
Other examples of situations in which the complement pathway
ids cell migration have been reported. Kurihara and colleagues
ound that C5a promotes collective migration in endothelial cells
uring angiogenesis [58]. Complement components may  also play
 direct role in cell adhesion: it has been shown that myoblasts,
or example, can adhere to a substrate via an interaction between
ntegrin receptors and vitronectin (S-protein)-bound SC5b-9 com-
lex (Fig. 1) [59]. Similarly, it appears that C3 may  interact with the
xtracellular matrix proteins ﬁbronectin and laminin [60,61]. How-
ver, at least in the context of neural crest migration, C3a–C3aR
ignalling does not exert its effect by inﬂuencing adhesion [12].
he physiological relevance of the complement system’s effect on
ell–matrix interaction remains to be determined.
A recent study provided an additional example of the comple-
ent pathway’s role in morphogenesis. In studies examining neural
ube closure, the authors found that C5a and C5aR are expressed
nd localised to the neural tube of developing mammals and that
oss of C5aR signalling exacerbates neural tube defects associated
ith folic acid restriction [14]. Using both pharmacological C5aR
lockade and genetic loss of C5aR, the authors observed that loss
f C5aR signalling, when combined with dietary folic acid restric-
ion, led to increased incidence of neural tube defects than folic
cid restriction alone. These data indicate that C5a–C5aR signalling
s involved in neurulation, but suggest that this role may  be redun-
ant with other signalling pathways and that it, therefore, may  only
ecome apparent during periods of dietary stress.
.3. Regeneration
Throughout development and in adult life, cells must recognise
nvironmental cues and respond in an appropriate way. As we have
een, the complement system plays an integral part of this process
n some situations. The forces driving immune responses, morpho-
enesis and developmental cell fate decisions are only effective if
ells are able to interpret external signals correctly. Another pro-
ess that uses many of the same signals to drive morphogenesis and
ell fate decisions is organ regeneration [62], and it seems that the
omplement pathway is heavily involved. A more detailed review
f how the complement system affects regeneration appears else-
here in this issue, but due to similarities to processes covered
bove we have included a short description here.
Regeneration is an extraordinary process. It involves cleaning
p a wounded area, mounting a defence against possible inva-
ion during the vulnerable state, dedifferentiation of resident cells,
emodelling of the extracellular matrix (ECM), redifferentiation
nd, ﬁnally, growth. While the immune system is important for
leaning up the wound and defending against infection, it may  alsomunology 25 (2013) 39– 46 43
be important for other parts of the regeneration process. C3, for
example, is found in myoblasts at sites of regeneration, suggesting
a possible role in the differentiation of skeletal muscle [63,64].
To study possible involvement of complement system com-
ponents in regeneration, Del Rio-Tsonis and colleagues turned to
animals that are famous for their regenerative potential, the sala-
mander. They found that C3 is expressed in both dedifferentiating
and redifferentiating limb tissue [65]. This might indicate a possi-
ble role in development, although that notion is confounded by the
authors’ observation that C3 expression is absent during normal
limb development.
Might this ﬁnding reﬂect a role for C3 independent of its involve-
ment in the complement cascade, or might it instead be our ﬁrst
hints that more of the complement cascade is involved in regen-
erative processes? Clues to this question have come from studies
on positional identity of regenerative structures. In a screen to
identify cell surface proteins whose expression varies with the
proximal–distal position of the wound, da Silva and colleagues
identiﬁed the newt orthologue of CD59, a negative regulator of later
stages of complement activation (Fig. 1) [66]. Similarly, Kimura and
colleagues showed that both C3 and C5 are involved in regeneration
of urodele newt limbs (Fig. 2C) and lenses [67], although the sig-
niﬁcance of the exact spatial distribution of these proteins remains
somewhat of a mystery.
Is the complement pathway’s involvement in regeneration
limited to urodeles or might these observations point to a more
general property of the pathway? To answer that question, Mas-
tellos and colleagues examined its regenerative involvement in a
system much closer to our own: liver regeneration in mice [68].
Using a murine model for liver toxicity, they found that mice lacking
C5 were severely deﬁcient in their ability to regenerate damaged
livers. In contrast to damaged livers in otherwise normal mice,
damaged livers in C5-deﬁcient mice were prone to necrosis and
slow to enter the cell cycle, and both defects were rescued by
the administration of exogenous C5 protein. The authors further
showed that this regenerative role of C5 occurs via its proteo-
lytic C5a fragment and the corresponding receptor, C5aR, rather
than via C5b-mediated MAC  assembly. These ﬁndings have since
been supported by studies examining liver regeneration after par-
tial hepatectomy, which have shown that both C3a and C5a are
required for the survival of liver cells [69–72]. Interestingly, Clark
and colleagues found that in the context of liver regeneration, C3
activation occurs independently of all three upstream complement
pathways [72].
We have highlighted several examples of non-immunological
roles of the complement pathway, and described how signalling
events in the complement pathway help to drive a number of devel-
opmental processes. It is interesting to note that none of these
processes appear to include the formation of the C5b-9 membrane
attack complex. Yet a growing body of evidence suggests that the
MAC may  also have signalling roles independent of its role as a
mediator of cell lysis. In the following section we will explore some
of the other signalling effects of various components of the com-
plement pathway, including the terminal MAC.
3. Complement-mediated signalling
As we have shown, the complement system underlies a num-
ber of developmental processes. Yet our understanding of exactly
how it exerts its effects is, in many instances, poor. As we learn
more about many of these processes, we  begin to appreciate that
complement signalling recruits a large number of signal transduc-
tion pathways (reviewed in [5]), many of which are also involved in
driving developmental processes. While a comprehensive analysis
of the many ways in which the complement system uses signal
4 s in Im
t
a
o
t
t
o
p
l
c
a
F
p
f
f
i
c
g
m
t
s
t
S
g
D
[
h
p
t
i
s
t
i
h
l
t
w
t
a
s
c
a
[
m
b
b
t
a
i
a
h
C
d
b
d
o
c
o
b
r
a
C
c
[
[
[
[
[
[
[4 J.D. Leslie, R. Mayor / Seminar
ransduction pathways is beyond the scope of this review, it is
ppropriate to highlight a few of the more conspicuous examples
f processes driven by the complement pathway and the signal
ransduction systems they employ.
Cross-talk between the complement system and other signal
ransduction pathways has been well-documented in the context
f innate immunity and cytokine production. For example, com-
lement and TLR signalling have been shown to converge at the
evel of downstream MAPK signalling via Erk1/2 and Jnk [73]. The
onvergence of the complement system with Erk1/2 and Jnk also
ppears to mediate some aspects of non-lytic complement activity.
or example, C3a has been shown to mediate Sdf1-triggered Erk1/2
hosphorylation during neural progenitor cell migration and dif-
erentiation [51]. Additionally, sublytic doses of C5b-9 have been
ound to activate Erk and Jnk in a variety of other contexts, includ-
ng protection to subsequent complement attacks [74,75] and cell
ycle progression [76–78].
The ability of the complement pathway to drive cell cycle pro-
ression also appears to recruit other signalling pathway. In a
urine model of kidney disease, sublytic MAC  has been shown
o promote proliferation and cell cycle progression via PI3K/Akt
ignalling [79,80]. Interestingly, this effect also appeared to have
he effect of stimulating the deposition of extracellular matrix.
imilarly, Shankland and colleagues have found that in cultured
lomerular visceral epithelial cells, the C5b-9 complex induced
NA synthesis but had a striking negative effect on cell division
81]. Other members of the complement system also appear to
ave proliferative effects: C5a and C5aR can drive cell proliferation,
resumably independent of MAC  formation [58,82]. In some cases,
he proliferative effects of the complement pathway also seem to
nvolve the activity of RGC-32, which promotes cell cycle progres-
ion, in turn, through the activity of Akt signalling [5,83]. While
he evidence linking the complement pathway to cell proliferation
s compelling, whether these effects of the complement pathway
ave roles during normal development remains to be determined.
As a testament to the complexity of complement signalling, sub-
ytic doses of MAC  can have an opposite affect, inducing apoptosis
hat is driven, not by passive lysis, but rather by signalling path-
ays. In a murine model of kidney disease, the Wang lab has shown
hat sublytic MAC  induces apoptosis via the activation of three pro-
poptotic molecules, IRF-1, Gadd45 and ATF3 [84–86]. Similarly,
tudies by the Okada lab have shown that C5a–C5aR signalling
auses apoptosis in neuroblastoma cells. This effect was  associ-
ted with inward calcium currents and nuclear c-fos accumulation
87,88]. C5a has also been shown drive thymocyte and adrenal
edulla cell apoptosis in sepsis models, an effect that appears to
e dependent upon caspase activation [89–92]. Additionally, inhi-
ition of C5aR in cultured mouse brain endothelial cells appeared
o block nuclear factor-B (NF-≡)-driven apoptosis and caspase
ctivation [93]. Others have shown that C5b-9 can activate NF-B
n some contexts [94,95]. Whether C5aR- and C5b-9-driven NF-B
ctivation are related remains to be determined.
Recently, a rather unexpected role of the complement pathway
as come to light. Naito and colleagues found that C1q, via C1r and
1s activation (Fig. 1), can drive canonical Wnt  signalling indepen-
ently of the Wnt  ligand itself [96]. The authors showed that C1q
inds to the Wnt  receptor Frizzled, and this in turn triggers C1s-
riven cleavage of the Wnt  co-receptor LRP6 and the stabilisation
f -catenin, with a concomitant increase in the transcription of
anonical Wnt  pathway target genes. It appears that this function
f complement-mediated Wnt  pathway activity is largely responsi-
le for the reduced regenerative capacity that comes with ageing:
emoval of C1q in muscle injury models of regeneration enabled
ged mice to regenerate as if they were young. This action of
1q–C1r–C1s appears to operate independently of downstream
omplement pathway components, illustrating that complement
[munology 25 (2013) 39– 46
signalling can feed into other signalling pathways at multiple places
along the pathway.
These ﬁndings underscore the notion that we are just beginning
to understand some of the varied ways that the complement sys-
tem affects development. Indeed, the Wnt  pathway is critical from
the earliest stages of development through adulthood and old age
[97,98]. It seems likely, then, that complement-driven Wnt  acti-
vation, as well as other complement-mediated signalling events,
occurs in a variety of developmental contexts that we  have yet to
uncover. We  have shown several examples of convergence points
between the complement pathway and other signalling pathways.
While many of these have come to light via studies on disease
progression, it seems likely that they may  also drive other pro-
cesses that occur during periods of normal health and development.
Indeed, many of these signal transduction pathways are critical for
driving cell behaviour and cell fate decisions throughout devel-
opment and in adult life. As we  learn more about the intricacies
of complement action we  will undoubtedly discover additional
complement-driven events that are involved in development, and
in so doing, will shed light on novel mechanisms driving cell–cell
communication.
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